Concord Medical Services Stock Analysis

Concord Stock Analysis Notes

About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 9.82. Concord Medical Services last dividend was issued on the 23rd of December 2015. The entity had 1:10 split on the 30th of July 2024. Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people. For more info on Concord Medical Services please contact Jianyu Yang at 86 10 5903 6688 or go to https://www.concordmedical.com.

Concord Medical Services Investment Alerts

Concord Medical Services Upcoming and Recent Events

Concord Largest EPS Surprises

View All Earnings Estimates

Concord Medical Environmental, Social, and Governance (ESG) Scores

Concord Medical Thematic Classifications

Concord Stock Institutional Investors

Note, although Concord Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Concord Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 24.92 M.

Concord Profitablity

The company has Net Profit Margin of (0.8) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (2.02) %, which entails that for every $100 of revenue, it lost $2.02.

Management Efficiency

Concord Medical Services has Return on Asset of (0.0521) % which means that on every $100 spent on assets, it lost $0.0521. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3876) %, meaning that it generated no profit with money invested by stockholders. Concord Medical's management efficiency ratios could be used to measure how well Concord Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of July 2025, Return On Equity is likely to grow to 0.14, while Return On Tangible Assets are likely to drop (0.06). As of the 22nd of July 2025, Debt To Assets is likely to grow to 0.61, while Total Assets are likely to drop about 4.2 B.

Technical Drivers

As of the 22nd of July, Concord Medical shows the Risk Adjusted Performance of 0.1118, downside deviation of 7.05, and Mean Deviation of 4.66. Concord Medical Services technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Concord Medical Services jensen alpha, as well as the relationship between the potential upside and skewness to decide if Concord Medical Services is priced correctly, providing market reflects its regular price of 5.66 per share. Given that Concord Medical has jensen alpha of 0.563, we suggest you to validate Concord Medical Services's prevailing market performance to make sure the company can sustain itself at a future point.

Concord Medical Services Price Movement Analysis

Concord Medical Outstanding Bonds

Concord Medical Predictive Daily Indicators

Concord Medical Corporate Filings

Concord Medical Forecast Models

Concord Medical's time-series forecasting models are one of many Concord Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Concord Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Concord Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Concord shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Concord Medical. By using and applying Concord Stock analysis, traders can create a robust methodology for identifying Concord entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.